Электронный архив открытого доступа НИУ «БелГУ»: Search

BelSU

Search

Search:
for

Current filters:

Start a new search

Add filters:

Results/Page | Sort items by In order Authors/record

Results 21-30 of 37 (Search time: 0.031 seconds).

previous
1
2
3
4
next

Item hits:

Issue Date	Title	Author(s)
2016	Cardiovascular effects of an arginase II selective inhibitor	Yakushev, V. I.; Pokrovskii, M. V.
2016	New approaches of morfofunktional pharmacological correction of violations of cardiovascular system in experimental preeclampsia	Gureev, V. V.
2015	The study of osteoprotective properties of nanoparticulated forms of resveratrol and losartan	Koklina, N. Y.; Gudyrev, O. S.; Faitelson, A. V.
2015	Use of selective inhibitors of arginase 2 and tadalafil in combined compensation of homocysteine-induced endothelial dysfunction	Koklin, I. S.
2015	Concomitant use of statins and s-(2-boron-ethyl)-l-cysteine arginase inhibitor to correct endotoxin-induced endothelial dysfunction	Denisiuk, T. A.; Demchenko, S. A.; Saroyan, K. V.
2017	Lipid distress-syndrome and prospects of its correction by statines	Denisiuk, T. A.; Lazareva, G. A.; Provotorov, V. Y.
2020	Correction of morphofunctional disorders of the cardiovascular system with asialized erythropoietin and arginase II selective inhibitors KUD 974 and KUD 259 in experimental preeclampsia	Lokteva, T. I.; Rozhkov, I. S.; Gureev, V. V.; Gureeva, A. V.; Zatolokina, M. A.
2017	Nuclear factor kappa B as a potential target for pharmacological correction endothelium-associated pathology	Ragulina, V. A.; Kostina, D. A.; Dovgan, A. P.; Burda, Y. E.; Nadezhdin, S. V.
2020	Role of Arginase 2 as a potential pharmacological target for the creation of new drugs to correct cardiovascular diseases	Demchenko, S. A.; Koklin, I. S.; Koklina, N. Y.
2017	Interleukin-6 is a potential target for a correction of endothelial dysfunction associated with low-grade systemic inflammation	Kostina, D. A.; Pokrovskaya, T. G.; Beskhmelnitsyna, E. A.